dr. park on the benefit of trastuzumab deruxtecan in her2 breast cancer
Published 4 years ago • 341 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
1:05
dr. hamilton on the optimal duration of trastuzumab in her2 breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
5:26
trastuzumab deruxtecan shows benefit in patients with her2 mbc
-
1:07
dr. hamilton on the destiny-breast01 trial in her2 breast cancer
-
8:42
trastuzumab deruxtecan in her2 breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
1:35
dr. sanft on treatment options in her2-positive breast cancer
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
6:58
her2climb and nala trials: r/r her2 mbc
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
1:40
dr. esteva on clinical trial design of trastuzumab biosimilar in her2 breast cancer
-
7:30
aphinity trial in her2 breast cancer
-
1:01
dr. hamilton on research needed in her2-positive breast cancer
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer